Development and Improvement of Substitution Programmes: Proceedings, Volume 527The seminar pooled experience of substitution treatment in European countries, reported on evaluations that have been made of existing programmes and took stock of developments resulting from changes in routes of administration and in the drug market. |
Contents
| 7 | |
Common features and diversity of approaches | 55 |
Difficulties encountered in postSoviet countries | 83 |
Difficulties encountered in Central and Eastern European countries | 107 |
Differential indications for the use of the various substitution | 119 |
Session | 135 |
Mortality from overdose | 155 |
Integration as a basic principle | 185 |
John Marsden | 203 |
Boguslaw Habrat 107 | 213 |
Appendix I | 219 |
Other editions - View all
Common terms and phrases
accepted activity agonist AIDS alcohol approach authors behaviour buprenorphine cantonal cause centre clinical cocaine comparing controlled countries criteria dependence depression detoxification dosage dose drug addicts drug users effects Email Europe European evaluation evidence experience factors Figure France Geneva heroin hospital important improved increase indications individuals injecting institutions integration involved issues Italy LAAM less limited major medicine methadone maintenance treatment months naltrexone opiate opioid opioid dependence outcome overdose patients persons population positive possible practice prescribed prescription prevalence prevention prison problems professionals programme psycho-social psychological public health receive reduce regional reported responsibility retention risk seen showed situation social specialised studies substance abuse substances substitution treatment symptoms taken taking testing therapeutic treated treatment programme trial